不同剂量右美托咪定对老年骨科手术患者术后谵妄的预防效果及安全性

:-
 
【摘要】目的:探讨不同剂量右美托咪定对老年骨科手术患者术后谵妄的预防作用。方法:回顾性选取2022年11月至2025年11月本院收治的116例老年骨折手术患者为研究对象,根据右美托咪定维持剂量不同分为0.2μg/(kg·h)的小剂量组(58例)和0.4μg/(kg·h)的大剂量组(58例)。比较两组不同时间点[麻醉诱导前(T0)、麻醉诱导后30 min(T1)、术闭即刻(T2)]的血压(收缩压、舒张压)、心率、应激反应指标[皮质醇(COR)、肾上腺素(E)、去甲肾上腺素(NE)];采用简易智力状态检查量表(MMSE)评估两组患者术前、术后12 h、术后24 h、术后48 h的认知功能水平;统计两组患者术后谵妄及围术期不良反应发生情况。结果:小剂量组T1、T2时收缩压、舒张压和心率均高于大剂量组(P<0.05)。小剂量组T1、T2时COR、E和NE均低于大剂量组(P<0.05)。小剂量组术后12h、术后24h、术后48h的MMSE评分均高于大剂量组(P<0.05)。小剂量组术后谵妄发生率8.62%(5/58)显著低于大剂量组22.41%(13/58)(χ2=4.209,P=0.040)。小剂量组不良反应总发生率12.07%(7/58)与大剂量组20.69%(12/58)对比无显著差异(P>0.05)。结论:与0.4μg/(kg·h)的大剂量右美托咪定相比,0.2μg/(kg·h)的小剂量在老年骨科手术麻醉中应用效果更佳,能有效维持血流动力学稳定、减轻应激反应、保护认知功能,对术后谵妄具有更好的预防作用,且安全性良好,值得在临床推广应用。
论著

右美托咪定联合丙泊酚或依托咪酯对颅内动脉瘤介入术患者围插管期血流动力学的影响

Effect of dexmedetomidine combined with propofol or etomidate on periintubation hemodynamics in cerebral aneurysm patients

:1043-1048
 
目的 探讨右美托咪定(Dex)分别联合丙泊酚或依托咪酯在颅内动脉瘤介入术中的镇静效果及对患者血流动力学的影响。方法 将60例颅内动脉瘤介入术患者按照随机数表法分为A组(Dex+丙泊酚,n=30)、B组(Dex+依托咪酯,n=30)。记录两组不同时间点的平均动脉压(MAP)、心率(HR),比较苏醒期的镇静效果、呛咳程度、拔管时间、苏醒时间、清醒时间及术后不良反应。结果 A组患者T1MAP、HR为(84.56±5.13)mmHg、(65.87±5.14)次/分和T2(83.29±5.47)mmHg、(65.87±5.14)次/分均低于B组T1(87.89±3.88)mmHg、(70.22±5.67)次/分和T2(86.71±3.75)mmHg、(69.97±5.87)次/分(t分别为2.836、2.825、3.113、3.391,均P<0.001)。两组苏醒期各项指标和躁动(10.00% vs 0%,P=0.757)、呼吸抑制发生率(3.33% vs 0%,P=0.313)比较差异均无统计学意义(均P>0.05),A组恶心、呕吐发生率(3.33%)较B组(20.00%)更低(χ2=4.043,P=0.044)。结论 Dex联合丙泊酚、依托咪酯麻醉在颅内动脉瘤介入术中均可发挥良好安全的麻醉作用,降低患者术后躁动和呼吸抑制的发生率,使用Dex联合依托咪酯在患者围插管期的血流动力学的稳定性效果更好,但在降低患者术后恶心呕吐的风险方面效果较差。
Objective To evaluate the sedative effect of dexmedetomidine(Dex)combined with propofol or etomidate during cerebral aneurysm intervention and its effect on patient hemodynamics.Methods A total of 60 cerebral aneurysm patients were randomly divided into two groups:Group A(Dex + propofol,n=30)and Group B(Dex + etomidate,n=30).Mean arterial pressure(MAP)and heart rate(HR)were recorded at different time points in the two groups,and the sedation effect,choking degree,extubation time,waking up time,waking time and postoperative side effects were compared.Results T1 MAP,HR of(84.56±5.13)mmHg,(65.87±5.14)times / min and T2(83.29±5.47)mmHg,(65.87±5.14)times / min in group A were lower than those in group B T1(87.89±3.88)mmHg,(70.22±5.67)times / min and T2(86.71±3.75)mmHg,(69.97±5.87)times / min(t=2.836,2.825,3.113,3.391,all P<0.001).There was no significant difference in the incidence of emergence agitation(10.00 % vs 0.00 %,P=0.757)and respiratory depression(3.33 % vs 0.00 %,P=0.313)between the two groups(P>0.05).The incidence of nausea and vomiting in group A(3.33 %)was lower than that in group B(20.00 %)(χ2=4.043,P=0.044).Conclusions Dex combined with propofol and etomidate anesthesia can have a good and safe anesthesia effect in intracranial aneurysm intervention,and reduce the incidence of postoperative agitation and respiratory depression in patients.Hemodynamic stabilization during the tube phase is more effective,but less effective in reducing the risk of postoperative nausea and vomiting in patients.
临床诊疗

右美托咪定对二尖瓣置换术患者左右心室收缩和舒张功能的影响

:128-130
 
目的 探究右美托咪定对二尖瓣置换术患者左右心室收缩和舒张功能影响。方法 选我院2019年1月—2020年12月期间110例二尖瓣置换术患者为研究对象,以随机数字表法分为对照组、观察组,各55例,分别实施常规静脉复合麻醉、常规静脉复合麻醉+切皮后微量泵注右美托咪定(负荷剂量1 μg/kg,10 min后维持每小时0.5 μg/kg至术毕),比较2组麻醉诱导后(T0)、体外循环(CPB)停机后30 min(T1)、CPB停机后60 min(T2)血流动力学指标,心肌损伤因子水平、左右心室收缩及舒张功能。结果 T1、T2时2组患者心率(HR)较T0高,平均动脉压(MAP)较T0低(P<0.05);2组各时间点HR、MAP比较未见统计学差异(P>0.05);T2时2组肌钙蛋白Ⅰ、肌酸激酶同工酶水平较T0时高,观察组T2时以上指标较对照组低(P<0.05);各时间点2组二尖瓣瓣环等容收缩期峰值速度、三尖瓣舒张早期血流峰值速度/三尖瓣环舒张早期血流峰值速度无差异(P>0.05);T2时观察组二尖瓣舒张早期血流速度峰值/二尖瓣瓣环舒张早期峰值速度、三尖瓣瓣环等容收缩期峰值速度较对照组低(P<0.05)。结论 在二尖瓣置换术中使用右美托咪定,可减少患者心肌功能损伤,改善心室心肌舒张、收缩功能。
临床诊疗

右美托咪定与咪达唑仑在儿童牙科患者术前镇静中的临床应用

:108-111
 
目的 探讨右美托咪定与咪达唑仑在儿童牙科患者术前镇静中的作用及安全性。方法 选取2020年6月—2021年1月需行择期全麻牙科治疗的60例患儿作为研究资料,将其根据数字法随机分为对照组(采取咪达唑仑)与观察组(采取右美托咪定)各30例,比较2组患儿的镇静效果。结果 2组患儿经麻醉后,观察组患儿的自主呼吸恢复时间、苏醒时间以及拔管时间低于对照组,经统计学分析有差异(P<0.05);患儿在给药前Ramsay镇静评分中比较无差异;在给药10 min、20 min、30 min时Ramsay镇静评分均能达到2分以上,但经统计学比较无差异;血氧饱和度未发现异常,而且在给药观察期间患儿的血氧饱和度也在95%以上;但经统计学分析,患儿在给药前和给药10 min、20 min、30 min时心率、呼吸以及血氧饱和度均无差异(P>0.05)。结论 右美托咪定与咪达唑仑均能成功用于儿童牙科患者术前镇静中,但经本文研究发现右美托咪定其效果更为显著些,而且绝大多数患儿能够配合与父母分离、配合麻醉面罩,降低患儿术后躁动发生率。
论著

小剂量右美托咪定改善臂丛神经阻滞效果的随机对照研究

Low dose of dexmedetomidine as an adjunction to ropivacaine in supraclavicular brachial plexus block: a randomized controlled trial

:20-26
 
目的 观察右美托咪定作为佐剂对罗哌卡因在锁骨上入路臂丛神经阻滞效果的影响。方法 将55例上肢择期手术的受试者随机分为右美组和对照组。右美组:30 μg右美托咪定(0.3 mL)+0.5%罗哌卡因,对照组:生理盐水(0.3 mL)+0.5%罗哌卡因。在臂丛神经阻滞操作后,按步骤评估和记录臂丛感觉、运动阻滞程度和起效时间。在术中定期监测和记录生命体征、不良事件的发生。手术后评估和记录术毕24小时生命体征、术后镇痛时间、臂丛神经感觉、运动阻滞的持续时间、术后恶心呕吐评分、补救镇痛药物用量和不良事件等数据。结果 在臂丛神经的感觉和运动起效时间、感觉和运动阻滞持续时间、术后镇痛时间方面,右美组长于对照组,存在统计学差异(P<0.05)。两组间在术后生命体征变化、补救镇痛药物用量、术后恶心呕吐评分、不良事件等数据的比较,未见明显统计学差异(P>0.05)。结论 右美托咪定(30 μg)作为佐剂能加快罗哌卡因在锁骨上入路对臂丛神经阻滞的起效时间,增加其术后镇痛时间和对臂丛神经的感觉、运动阻滞时间,同时较少影响患者生命体征,具备一定的有效性和临床安全性。
Objective To observed the effect of dexmedetomidine as an adjunction with ropivacaine in supraclavicularbrachial plexus block. Methods 55 subjects with elective upper extremity operation were randomly divided into two groups: DEX group and control group. The drugs in DEX group was 30 μg dexmedetomidine (0.3 mL) + 0.5% ropivacaine, 20 mL in total. And the one in control group was normal saline (0.3 mL) +0.5% ropivacaine, 20 mL in total. After the operation of brachial plexus block, the value of sensory and motor block of brachial plexus and the onset time were evaluated and recorded according to the protocol. Vital signs and adverse events were monitored and recorded regularly during the operation.Postoperative vital signs, postoperative analgesia time, duration of brachial plexus sensationsensory and motion block, postoperative nausea and vomiting score, dosage of remedial analgesics and adverse events were assessed and recorded in 24 hours after surgery. Results In terms of sensory and motor onset time of brachial plexus, duration of sensory and motor block and postoperative analgesia, DEX group was longer than the control group, with statistical differences (P<0.05).There were no significant statistical differences between the two groups in postoperative vital signs, the amount of remedial analgesic drugs, postoperative nausea and vomiting scores, adverse events etc(P>0.05). Conclusion As an adjuvant, dexmedetomidine (30 μg) can accelerate the onset time of ropivacaine in the supraclavicular approach of brachial plexus block.It can also increase the postoperative analgesia time and sensory and motor block time of brachial plexus.With less impact on the vital signs of patients, the efficacy and clinical safety of dexmedetomidinecan be found in our study.
论著

不同剂量阿托品对右美托咪定心脏窦房结及房室结抑制作用的逆转效果

Reversal effect of atropine on the function of sinus node and the atrioventricular node inhibiting action by dexmedetomidine

:33-36
 
目的 观察两种不同剂量的阿托品对右美托咪定心脏窦房结及房室结抑制作用的逆转效果。方法 健康志愿者20名,男12名,女8名,18~30岁。受试者先后给予右美托咪啶(1.5±0.5)μg/kg负荷量,持续泵注量(0.75±0.25)μg/(kg·h)进行试验观察。试验过程中如受试者心率<(50±5)次/分,房室结前传2∶1小于150次/分的受试者随机进入0.5 mg阿托品剂量拮抗组(A1),1 mg阿托品剂量拮抗组(A1),每组10例。与泵注前(T0),静脉泵注右美托咪定后(50±5)min(T1),阿托品静脉推注后(10±5)min(T2)经食道左心房调搏测定窦房结恢复时间(SNRT),校正窦房结恢复时间(CSNRT),房室结前传2∶1点阻滞点和房室结有效不应期(AVNERP)测量。结果 组内比较:泵注右美托咪定后T1时点与基础值T0时点比较两组窦房结及房室结功能受到抑制,SNRT 均延长(P<0.05),CSNRT比较无差异(P>0.05),房室结前传2∶1阻滞点降低(P<0.05), AVNERP延长(P<0.05)。阿托品使用后T2时点的A1组的各指标及A2组的AVNERP恢复到基础水平(P>0.05),A2组的SNRT、CSNRT均较T0时点缩短(P<0.05),A2组房室结前传2∶1阻滞点均较T0时点增高(P<0.05)。组间比较:2组T0时窦房结及房室结功能各指标比较均无差异(P>0.05),T2时点A2组SNRT、AVNERP较A1缩短(P<0.01),T2时点A2组2∶1阻滞点均较A1组增高(P<0.05)。结论 0.5 mg阿托品能逆转右美托咪定心脏窦房结及房室结抑制作用,1 mg阿托品增进右美托咪定影响下的窦房结及房室结传导功能。
Objective To investigate two different doses atropine make reverse effects on the function of sinus node and the atrioventricular node inhibiting action dexmedetomidine (Dex). Methods 20 healthy volunteers were included in the clinical trials aged 18~30 years (12 male, 8 female). The volunteers were administered with Dex at loading dose 1.5±0.5 μg/kg and then at 0.75±0.25 μg/(kg·h). During the trail, the volunteers who happened the minimal heart rate less than 50±5 bpm, atrioventricular node forward 2∶1 block point less than 150 bpm needed to randomly accept 0.5 mg(group A1)or 1 mg(group A2)atropine to antagonize(n=10). SNRT, CSNRT, AVN 2∶1 block point and AVNERP were recorded through TELAP. Results Intra-group comparison indicated functional parameters of SN and AVN were inhibited by Dexsat T1. SNRT were prolonged (P<0.05), AVN 2∶1 block point were decreased (P<0.05),AVNERP were prolonged at T1 compared with T0(P<0.05). All indexes in group A1 and AVNERP in group A2 were back to basal level after using atropine at T2(P<0.05). SNRT, CSNRT were shorted at T2 compared with T0 in group A2(P<0.05). AVN 2∶1 block point had more increased at T2 compared with T0 in group A2(P<0.05). Inter-group comparison indicated no significant differences in functional parameters of SN、AVN at T0(P>0.05). SNRT, AVNERP were shorted at T2 in group A2 compared with group A1. AVN 2∶1 block point were increased at T2 in group A2 compared with group A1. Conclusion 0.5 mg atropine may reverse the function of SN and AVN that are inhibited by Dex. 1 mg atropine may increase functions of SN and AVN that are inhibited by Dex.
临床诊疗

不同剂量右美托咪定对腰硬联合麻醉下经皮肾镜碎石术患者的镇静效应和安全性研究

Safety and sedative effect of different dose of Dexmedetomidine in percutaneous nephrolithotomy under combined spinal epidural anesthesia

:76-80
 
目的 探讨不同剂量右美托咪定(Dex)对腰硬联合麻醉下经皮肾镜碎石术患者的镇静效应和安全性。方法 腰硬联合麻醉下行俯卧位经皮肾镜碎石术患者80例,随机分成4组。D1组、D2组、D3组俯卧位后静脉泵注负荷剂量DEX 0.5 μg/kg,输注的时间为10min,随后分别静脉泵注DEX 0.3 μg/(kg·h)、0.5 μg/(kg·h)、 0.7 μg/(kg·h)至术毕;C组俯卧位后静脉泵注生理盐水10 mL/h至术毕。记录T0~T6共7个时点的HR、MAP、p(O2)和BIS值;在T0、T3~T6等时点对患者静息Ramesay镇静评分;观察患者不良反应发生情况;询问综合满意度。结果 D2组和D3组的HR、MAP、BIS、Ramesay镇静评分在T3~T6等时点明显慢于C组(P<0.05);D3组心动过缓和头晕等不良反应的发生率明显高于D1组、D2组和C组(P<0.05),D2组和D3组术中躁动的发生率明显低于D1组和C组(P<0.05),D1组、D2组和D3组高血压、寒战和恶心呕吐的发生率明显低于C组(P<0.05),且综合满意度明显高于C组。结论 DEX本药物用于该类手术的镇静疗效及安全性均优于对比的药物。建议临床使用剂量为DEX负荷剂量0.5 μg/kg,随后以0.5 μg/(kg·h)维持。
论著

血塞通联合右美托咪定对老龄大鼠脑缺血再灌注损伤的保护效果研究

Effects of Xuesaitong combined with dexmedetomidine on cerebral ischemia-reperfusion injury in elderly rats

:918-923
 
       目的   评价血塞通联合右美托咪定对脑缺血再灌注损伤大鼠的脑保护效果。方法   选择老龄雄性Wistar大鼠50只,随机分为假手术(C)组、脑缺血再灌注(R)组、血塞通(P)组、右美托咪定(D)组,血塞通联合右美托咪定(PD)组,每组各10只。根据组别给予不同药物,行神经行为学测试;于第3、7天,测量脑梗死面积、脑水含量,以及超氧化物歧化酶(Superoxide dismutase,SOD)、谷胱甘肽过氧化酶(Glutathione peroxidase,GSH-PX)活性测定。结果   给药后第3、5、7天,与P、D组相比,PD组神经行为学评分改善更加显著(P<0.001);给药后第3、7天,与P组相比,PD组脑梗死面积、脑水含量均降低(P=0.01,P=0.002),SOD、GSH-PX活性升高显著(P=0.03,P=0.001);与D组相比,PD组脑梗死面积、脑水含量也显著降低(P<0.01,P=0.008);SOD、GSH-PX活性升高显著(P=0.009,P<0.001)。结论   血塞通联合右美托咪定较单独应用药物,能显著减轻缺血再灌注损伤造成的脑损害,具有脑保护作用。
       Objective  To explore the effects of Xuesaitong combined with dexmedetomidine on cerebral ischemia-reperfusion in elderly rats.Methods  Fifty elderly male Wistar rats were randomly divided into 5 groups:sham operation(C)group,cerebral ischemia-reperfusion(R)group,Xuesaitong(P)group,dexmedetomidine(D)group,Xuesaitong combined with dexmedetomidine(PD)group.Xuesaitong was given in group P,dexmedetomidine was given in group D,and normal saline was given in group C and group R,continuously for 7 days.After 3- and 7-day treatment,the brain of rats was dissected out to assay the area of cerebral infarction,degree of cerebral edema,superoxide dismutaseSOD) and glutathione peroxidaseGSH-PX) activity.Results When compared PD group with P and D group,neurobehavioral score was lower at 3,5,7 day(P<0.001);area of cerebral infarction,degree of cerebral edema were less(P=0.01,P=0.002),activity of SOD and GSH-PX were higher at 3,7 days(P=0.03,P=0.001)respectively.When compared PD group with D group,area of cerebral infarction,degree of cerebral edema were less(P<0.01,P=0.008),activity of SOD and GSH-PX were higher at 3,7 days(P=0.009,P<0.001)respectively.Conclusions  The combination of Xuesaitong and dexmedetomidine can obviously reduce the damage by cerebral ischemia-reperfusion in elderly rats and has brain protective effects.
出版者信息








《广州医药》公众号